Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease

Ziang Li, Bin Zhang, Qing‐Rong Liu, +14

EBioMedicine

Deciphering genetic causes for sex differences in human health through drug metabolism and transporter genes

Yingbo Huang, Yuting Shan, Weijie Zhang, +4

Nature Communications

Oncogene or tumor suppressor? Long noncoding RNAs role in patient's prognosis varies depending on disease type

Yingbo Huang, Alexander Ling, Siddhika Pareek, +1

Translational research

OncologyOncogenic AgentMedicinePathologyCancer Genomics +10

Lipid-Coated, pH-Sensitive Magnesium Phosphate Particles for Intracellular Protein Delivery

Yunzhou Fang, Mallika Vadlamudi, Yingbo Huang, +1

Pharmaceutical Research

Lipid PreparationIntracellular Protein DeliveryBiomedical EngineeringDrug Delivery System

Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling

Weijie Zhang, Adam M. Lee, Sampreeti Jena, +10

Proceedings of the National Academy of Sciences

Castration-resistant Prostate CancersDrug TargetEngineeringTumor BiologyHormonal Therapies +14

Integration of Pan-Cancer Cell Line and Single-Cell Transcriptomic Profiles Enables Inference of Therapeutic Vulnerabilities in Heterogeneous Tumors

Weijie Zhang, Danielle Maeser, Adam M. Lee, +6

Cancer Research

Understanding <scp>Statin‐Roxadustat Drug–Drug‐Disease</scp> Interaction Using Physiologically‐Based Pharmacokinetic Modeling

Jin Dong, Luna Prieto Garcia, Yingbo Huang, +7

Clinical Pharmacology & Therapeutics

Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice

Ibrahim Y. Abdelgawad, Benu George, Marianne Grant, +4

Archives of Toxicology

A Long Noncoding RNA, GAS5 Can Be a Biomarker for Docetaxel Response in Castration Resistant Prostate Cancer

Yuting Shan, Yingbo Huang, Adam M Lee, +3

Frontiers in Oncology

Evaluation of bone mass in children and young adults with juvenile idiopathic arthritis.

Tingting Tang, Xuemei Tang, Li Xu, +3

PubMed